Clinical Trial Update: PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating perampanel (Fycompa) for prophylaxis of status epilepticus after cardiac arrest. Recruitment is currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Arrest
• Status Epilepticus

Drugs mentioned

• Fycompa (perampanel)

Snippet

Sponsor: University of California, San Francisco | Conditions: Heart Arrest, Seizures | Phase 2 | Status: RECRUITING